Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
68.21
-5.78 (-7.81%)
Apr 29, 2026, 1:08 PM EDT - Market open
Oruka Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Net Income | -105.43 | -91.34 |
| Depreciation & Amortization | 0.08 | 0.03 |
| Loss (Gain) From Sale of Investments | -5 | -2.45 |
| Stock-Based Compensation | 24.24 | 16.28 |
| Other Operating Activities | 0.46 | 1.74 |
| Change in Accounts Payable | -5.32 | 10.35 |
| Change in Other Net Operating Assets | 2.77 | 2.3 |
| Operating Cash Flow | -88.21 | -63.09 |
| Capital Expenditures | -0.21 | -0.21 |
| Investment in Securities | -96.54 | -359.93 |
| Investing Cash Flow | -96.75 | -360.14 |
| Total Debt Issued | - | 27.25 |
| Net Debt Issued (Repaid) | - | 27.25 |
| Issuance of Common Stock | 170.32 | 459.96 |
| Financing Cash Flow | 170.32 | 490.41 |
| Net Cash Flow | -14.64 | 67.17 |
| Free Cash Flow | -88.42 | -63.3 |
| Free Cash Flow Per Share | -1.94 | -3.77 |
| Levered Free Cash Flow | -55.83 | - |
| Unlevered Free Cash Flow | -55.83 | - |
| Change in Working Capital | -2.56 | 12.64 |
Source: S&P Capital IQ. Standard template.
Financial Sources.